The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.
Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.
Kickstart your journey in sustainable chemistry with GreenChem and Wiley! If you're a student or early-career researcher with a green idea, apply to become a finalist, get expert pitch training, and compete for prizes. No experience needed—just your passion for making an impact. Applications open soon!
November, 19 – 21, 2025 | All you want to know about advanced recycling technologies and renewable chemicals, building-blocks, monomers, and polymers based on recycling.
December 8 – 11, 2025 | The Annual GPCA Forum, the flagship event of the Gulf Petrochemicals and Chemicals Association (GPCA), has earned its reputation as the premier gathering of the chemical and petrochemical industry in the Arabian Gulf region. The 19th edition of the forum, which will take place under the motto “Catalyzing Competitiveness through Strategic Partnerships” in Bahrain, will once again include the GPCA StartUp Nexus.
Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.
Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.
